Mother-to-child HIV transmission occurs when the virus passes from an infected mother to her infant during pregnancy, delivery, or breastfeeding. Without intervention, HIV can cross biological barriers or reach the infant through infected blood and breast milk. Antiretroviral treatment, viral-load monitoring, planned delivery when appropriate, and carefully managed infant feeding have reduced transmission dramatically. As a result, increasing numbers of children are growing up HIV-free despite having experienced exposure to the virus and, in many cases, to antiretroviral medicines before birth.

The new review addresses an important scientific distinction between HIV infection and HIV exposure. Children living with HIV may experience direct effects of viral replication, inflammation, immune activation, and treatment. HIV-exposed but uninfected children do not carry the virus, yet their development may still be influenced by the biological and social conditions surrounding maternal infection. These can include prenatal inflammation, maternal illness, nutritional problems, socioeconomic stress, premature birth, and exposure to medications during critical stages of fetal brain development.

Neurodevelopmental disorders are not a single condition. They include difficulties affecting cognition, language, motor coordination, attention, learning, behavior, communication, and social interaction. Brain development begins before birth and continues through childhood, relying on tightly regulated processes such as neuronal migration, synapse formation, myelination, and the maturation of neural circuits. Disruptions to these processes may not become apparent immediately, which is why long-term developmental follow-up is important even when an infant appears healthy at birth.

In a systematic review, investigators search the scientific literature using predefined criteria, assess the quality of eligible studies, and compare results across different populations and research settings. A meta-analysis then combines quantitative findings when the studies are sufficiently comparable. This approach can increase statistical power, but it cannot eliminate differences in how researchers define HIV exposure, measure development, select comparison groups, or account for factors such as prematurity and maternal health.

The authors’ work brings together evidence on the relationship between perinatal HIV exposure and neurodevelopmental outcomes. The central issue is whether children exposed to HIV show higher rates of developmental difficulties than children who were neither exposed to HIV nor antiretroviral therapy. Any association identified in such research must be interpreted carefully: it may reflect a biological effect of maternal infection, treatment exposure, complications of pregnancy, or broader environmental circumstances rather than a single causal pathway.

Several mechanisms could plausibly connect maternal HIV infection with later developmental differences. Even when antiretroviral therapy suppresses the virus, chronic immune activation and inflammatory signaling may persist. Inflammation can influence the placenta, alter fetal immune development, and affect the chemical environment in which the brain forms. Maternal HIV may also be associated with anemia, co-infections, depression, inadequate nutrition, and reduced access to prenatal care. Each of these factors can independently influence early brain development, making it difficult to isolate the contribution of HIV exposure itself.

Antiretroviral drugs add another layer of scientific complexity. These medicines are essential for protecting the mother’s health and preventing transmission, and their benefits are overwhelmingly established. At the same time, researchers continue to study how different drug combinations might interact with fetal or infant development. Exposure does not necessarily mean harm, and an observed association cannot automatically be attributed to medication. The timing of exposure, drug concentration, genetic susceptibility, placental transport, and the health consequences of untreated maternal HIV all need to be considered together.

The findings have practical implications for pediatric care and public health. They do not weaken the case for preventing mother-to-child transmission; rather, they support a broader model of care in which HIV-exposed infants receive both infection surveillance and developmental monitoring. Early screening for language, motor, cognitive, behavioral, and social difficulties can allow families to access speech therapy, educational support, developmental pediatrics, and other interventions before problems become entrenched. Future studies will need larger cohorts, standardized developmental assessments, longer follow-up, and comparison groups that account for maternal health, treatment history, birth complications, and social conditions.

The review also highlights how the success of HIV prevention has changed the scientific questions facing medicine. The priority is no longer only whether a child becomes infected, but also how prenatal exposure to maternal infection, treatment, inflammation, and environmental adversity may shape health across the life course. Understanding these relationships can help clinicians balance the extraordinary benefits of antiretroviral therapy with more precise developmental surveillance. For families affected by HIV, the goal is a complete picture of child health—one that includes freedom from infection as well as the opportunity for healthy neurological and developmental growth.

Subject of Research: The relationship between mother-to-child HIV exposure and neurodevelopmental disorders in children.

Article Title: Mother-to-child HIV exposure and its relation with neurodevelopmental disorders: a systematic review and meta-analysis.

Article References: Dantas, C.E.F., Lins, G.A.d.S.L., Soares, A.G.A. et al. Mother-to-child HIV exposure and its relation with neurodevelopmental disorders: a systematic review and meta-analysis. Pediatric Research (2026). https://doi.org/10.1038/s41390-026-05252-5

Image Credits: AI Generated

DOI: 10.1038/s41390-026-05252-5

Keywords: HIV, mother-to-child transmission, HIV-exposed uninfected children, neurodevelopment, developmental disorders, antiretroviral therapy, prenatal exposure, pediatric health, systematic review, meta-analysis

Executive functions, a constellation of higher-order cognitive processes including working memory, cognitive flexibility, and inhibitory control, are crucial for academic success and social adaptation. Preterm birth, defined as birth before 37 weeks of gestation, has long been associated with increased risks of neurodevelopmental challenges, yet the mechanisms underlying these risks have remained elusive. The team, led by Dereymaeker, Hermans, and Bollen, undertook an ambitious longitudinal study to chart the course of early brain physiology, particularly focusing on neonatal sleep architecture and its ramifications for executive function later in childhood.

Sleep, far from being a passive, inactive state, is fundamentally linked to brain development. In neonates, it is characterized by unique patterns identifiable via electroencephalography (EEG), including quiet sleep and active sleep phases. The researchers meticulously recorded neonatal EEG data in preterm infants, scrutinizing markers such as sleep spindles and delta brushes, which are considered hallmarks of cortical maturation and neural plasticity. These fine-grained physiological signals were then correlated with comprehensive neurocognitive assessments conducted when the children reached early school age.

What emerged from this extensive data collection was a compelling association: variations in the integrity and frequency of certain neonatal sleep features corresponded to measurable differences in early executive functioning. Notably, infants exhibiting more mature sleep spindle patterns tended to demonstrate enhanced cognitive flexibility and inhibition control during subsequent psychological testing. The implications of this finding extend beyond academic curiosity, charting a potential biomarker for early identification of at-risk infants who may benefit from targeted developmental support.

The study navigates the complex territory of neurodevelopmental trajectories, illustrating how preterm birth disrupts normative sleep physiology. Preterm infants often face fragmented sleep cycles, which may hinder the consolidation of synaptic connections essential for brain wiring. By linking these disruptions to executive function deficits observed years later, the research provides a biological substrate for cognitive vulnerabilities commonly observed in this population. Such insights could pave the way for refining neonatal care practices, including the optimization of sleep environments in neonatal intensive care units (NICUs).

Further enriching this narrative, the researchers explored potential confounding variables, including gestational age at birth, medical complications, and socioeconomic factors, ensuring that the identified associations were robust and not merely epiphenomena. Advanced statistical modeling underscored the independent predictive power of neonatal sleep features on executive function outcomes. This supports a causal interpretation that early neural oscillatory activity is integral to the shaping of executive circuits in the developing brain.

Technically, the study capitalizes on the integration of neonatal polysomnography with sophisticated neuropsychological batteries designed for children. The electrophysiological data were processed using state-of-the-art signal analysis techniques to extract sleep microarchitecture components, such as spindle density, frequency, and amplitude. These were mapped against neuropsychological constructs that probe inhibitory control, cognitive flexibility, and working memory capacity, thereby doing justice to the multifaceted nature of executive functioning.

By triangulating approaches from developmental neuroscience, clinical pediatrics, and cognitive psychology, the research transcends disciplinary boundaries. It situates neonatal sleep physiology not merely as a passive developmental milieu but as an active, modifiable determinant of long-term cognitive health. This paradigmatic shift challenges clinicians and researchers to rethink intervention opportunities during a narrow but critical window of brain plasticity in preterm neonates.

Moreover, the findings bear relevance to emerging neuroprotective strategies. For instance, certain non-invasive interventions may enhance neonatal sleep quality or modulate neural oscillations, potentially mitigating executive function impairments. Understanding the precise electrophysiological signatures tied to future cognitive outcomes creates the possibility of biofeedback or targeted neuromodulation therapies tailored to individual neural profiles in the NICU.

Equally important is the ethical dimension underscored by this research. The identification of sleep biomarkers linked to cognitive trajectories invites responsible use of predictive diagnostics. It also mandates supportive frameworks to ensure equitable access to early intervention resources for families of preterm infants, reinforcing the social imperative embedded in biomedical discoveries.

The research also charts new directions for future studies, including the exploration of how varying environmental stimuli in NICUs—such as lighting, noise, and caregiving practices—affect sleep physiology and downstream cognitive development. Interdisciplinary collaborations combining neuroscience, bioengineering, and clinical care will be essential to translate these findings into tangible improvements in neonatal health outcomes.

Critically, this study affirms the value of longitudinal research designs in uncovering the developmental cascades that begin in infancy and extend into childhood. It adds to a burgeoning literature that conceptualizes early life as a foundational period during which interventions may exert maximal impact in shaping neurocognitive resilience or vulnerability.

In sum, Dereymaeker and colleagues have contributed a landmark piece to the puzzle of how preterm birth interfaces with the developing brain’s electrophysiology and cognitive future. Their work underscores the promise of neonatal sleep as a dynamic biomarker and a potential target for therapeutic innovation. As neonatal care continues to advance, integrating insights from such research may ultimately transform clinical paradigms, optimize developmental trajectories, and improve lifelong outcomes for preterm children worldwide.

Beyond its technical sophistication, the study carries an emotional weight, highlighting the fragility and potential of the earliest human lives. It serves as a call to action for the scientific community, healthcare providers, and policymakers to harness neuroscience in the service of vulnerable infants whose futures hinge on the delicate dance of sleep waves within their burgeoning brains. This research heralds a new era in understanding and care, wherein neonatal sleep is not rest, but a vital, dynamic frontier for shaping the human mind.

Subject of Research: Neonatal sleep physiology and its impact on early executive functioning in preterm children

Article Title: Neonatal sleep physiology and early executive functioning in preterm children

Article References:
Dereymaeker, A., Hermans, T., Bollen, B. et al. Neonatal sleep physiology and early executive functioning in preterm children. Pediatr Res (2026). https://doi.org/10.1038/s41390-026-04784-0

Image Credits: AI Generated

DOI: 10.1038/s41390-026-04784-0

Executive function, a collective term encompassing the mental skills required for goal-directed behavior, is frequently impaired in children with ADHD. Deficits in working memory, inhibitory control, cognitive flexibility, and planning are well-documented, impeding academic performance and social interactions. Traditional pharmacological treatments, while effective for many, are not universally efficacious or without side effects, prompting researchers to investigate adjunctive or alternative interventions. Exercise, known for its neurobiological benefits, including increased neurotrophic factors and enhanced neurotransmitter modulation, has emerged as a promising candidate to support executive function improvement.

The study by Logan and Lim synthesizes findings from a breadth of clinical trials and observational studies, emphasizing the heterogeneity in exercise protocols, cognitive assessments, and participant characteristics. Aerobic exercise, characterized by sustained cardiovascular activity, appears most frequently studied, with some trials reporting significant improvements in attentional control and inhibitory function post-intervention. These improvements are often attributed to exercise-induced increases in brain-derived neurotrophic factor (BDNF) and enhanced dopaminergic transmission, both crucial for prefrontal cortex function where executive processes are localized.

However, the research underscores variability in outcome measures and exercise specificity. While acute bouts of moderate-intensity exercise yield transient improvements in executive performance, sustained intervention programs lasting several weeks demonstrate more robust and enduring effects. Nevertheless, the intensity, duration, and type of activity necessary to optimize cognitive gains remain elusive. Interdisciplinary evidence suggests that complex motor activities integrating cognitive demands, such as martial arts or dance, might offer superior benefits by simultaneously engaging executive control networks and sensorimotor integration pathways.

One pivotal aspect highlighted in the review is the developmental stage of participants. The neuroplastic potential and responsiveness to exercise in executive domains may vary considerably between early childhood, middle childhood, and adolescence. Younger children’s executive systems are still maturing, potentially rendering them more malleable to external stimuli like exercise. Contrastingly, older children might require more targeted or intensive interventions to elicit meaningful cognitive shifts. This developmental perspective calls for tailored exercise prescriptions sensitive to neurodevelopmental trajectories.

Moreover, this study confronts methodological challenges and inconsistencies that have historically muddled the field. Small sample sizes, lack of randomized controlled designs, and inconsistent executive function measurement tools complicate the derivation of definitive conclusions. Logan and Lim advocate for rigorous, large-scale longitudinal studies employing standardized cognitive assessments to parse out the nuances of exercise impact. They also emphasize the necessity to control for confounding variables such as medication status, comorbid conditions, and psychosocial factors that influence functional outcomes.

Intriguingly, neuroimaging studies complement this behavioral evidence by revealing exercise-related functional and structural brain changes in children with ADHD. Enhanced activation patterns in the prefrontal cortex post-exercise interventions suggest an underlying neurophysiological mechanism for improved executive control. Additionally, white matter tract integrity improvements following sustained physical activity lend credence to the notion that exercise fosters neurodevelopmental processes fundamental to cognitive function, including myelination and synaptic pruning.

The psychosocial advantages of incorporating exercise into ADHD management regimens cannot be overstated. Physical activity not only bolsters cognitive control but also promotes mood regulation, stress reduction, and social engagement—critical components often impaired in children with ADHD. The study argues that these holistic benefits could synergistically reinforce executive function improvements, creating a positive feedback loop enhancing overall quality of life.

From a translational perspective, Logan and Lim’s review urges clinicians, educators, and policymakers to consider exercise as a viable adjunct therapy. However, they caution against simplistic one-size-fits-all recommendations given the complex interplay of individual variability and intervention parameters. Incorporating personalized exercise programs that accommodate preferences, capacity, and comorbidities could enhance adherence and optimize cognitive outcomes.

A particularly striking insight from the paper is the role of exercise timing relative to cognitive tasks. Acute exercise immediately preceding challenging activities may prime the brain for enhanced executive engagement, a finding with practical implications for scheduling physical education and homework sessions. This temporal dynamic invites further exploration into dose-response relationships and the potential for combined cognitive-exercise training paradigms.

Furthermore, the study discusses emerging molecular insights linking exercise to epigenetic modulation in ADHD. Exercise-induced alterations in gene expression related to synaptic plasticity, neuroinflammation, and neurotransmitter metabolism could underpin the cognitive benefits observed. These mechanistic revelations point toward novel biomarkers for monitoring intervention efficacy and tailoring treatment strategies.

Despite promising findings, the review highlights gaps in knowledge, notably the long-term sustainability of exercise-induced executive improvements and the optimal modalities to maximize neurocognitive gains. Bridging these gaps requires interdisciplinary collaboration, integrating neuroscience, kinesiology, psychology, and pedagogy, to holistically address the multifaceted needs of children with ADHD.

In conclusion, Logan and Lim’s 2025 review encapsulates the current state of research on exercise interventions targeting executive function in children with ADHD. While definitive verdicts remain cautious due to methodological heterogeneity and limited longitudinal data, the convergence of behavioral, neurophysiological, and molecular evidence positions exercise as a compelling adjunctive approach. This work sets a foundation for future rigorous investigations poised to refine exercise prescriptions and unlock their full therapeutic potential in neurodevelopmental disorders.

Subject of Research: The impact of exercise interventions on executive function in children with attention-deficit/hyperactivity disorder (ADHD).

Article Title: Efficacy of exercise interventions for executive function in children with ADHD: What is the current verdict?

Article References:
Logan, N.E., Lim, M. E. Efficacy of exercise interventions for executive function in children with ADHD: What is the current verdict? Pediatric Research (2025). https://doi.org/10.1038/s41390-025-04646-1

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41390-025-04646-1